CD8 T cells producing IL-17 and IFN-γ initiate the innate immune response required for responses to antigen skin challenge

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 5949-5959

  Kish, Danielle D ^a   Li, Xiaoxia ^a,b   Fairchild, Robert L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 17; SILVER;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL TRANSFER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; INNATE IMMUNITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL1; CHEMOKINE CXCL2; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN TESTS;

EID: 74049159215     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802830     Document Type: Article

References (52)

1. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55: 97-179.
2. El-Sawy, T., J. A. Belperio, R. M. Strieter, D. G. Remick, and R. L. Fairchild. 2005. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112: 320-331.
3. Jaeschke, H., and C. W. Smith. 1997. Mechanisms of neutrophil-induced parenchymal cell injury. J. Leukocyte Biol. 61: 647-653.
4. McColl, S. R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163: 2829-2835.
5. Miller, A. L., R. M. Strieter, A. D. Gruber, S. B. Ho, and N. W. Lukacs. 2003. CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J. Immunol. 170: 3348-3356.
6. Moore, T. A., M. W. Newstead, R. M. Strieter, B. Mehrad, B. L. Beaman, and T. J. Standiford. 2000. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J. Immunol. 164: 908-915.
7. Campbell, J. J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D. P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780.
8. Reiss, Y., A. E. Proudfoot, C. A. Power, J. J. Campbell, and E. C. Butcher. 2001. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J. Exp. Med. 194: 1541-1547.
9. Engeman, T. M., A. V. Gorbachev, R. P. Gladue, P. S. Heeger, and R. L. Fairchild. 2000. Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization. J. Immunol. 164: 5207-5214.
10. Kripke, M., C. Munn, A. Jeevan, J. Tang, and S. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145: 2833-2838.
11. Macatonia, S. E., A. J. Edwards, and S. C. Knight. 1986. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 59: 509-514.
12. Macatonia, S. E., S. C. Knight, A. J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166: 1654-1667.
13. Enk, A. H. 1997. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol. Med. Today 3: 423-428.
14. + T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25: 3006-3010.
15. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144: 4121-4128.
16. + T cells. J. Exp. Med. 183: 1001-1012.
17. + T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions. J. Immunol. 166: 2323-2332.
18. + T cells. J. Immunol. 158: 4721-4728.
19. DiIulio, N. A., T. M. Engeman, D. Armstrong, C. Tannenbaum, T. A. Hamilton, and R. L. Fairchild. 1999. Groα-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur. J. Immunol. 29: 3485-3495.
20. Engeman, T. M., A. V. Gorbachev, D. D. Kish, and R. L. Fairchild. 2004. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J. Leukocyte Biol. 76: 941-949.
21. + T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism. J. Immunol. 172: 2286-2295.
22. + IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177: 6852-6858.
23. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
24. Backkevold, E. S., M. A. Wurbel, P. Kivisakk, C. M. Wain, C. A. Power, G. Haraldsen, and J. J. Campbell. 2005. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J. Exp. Med. 201: 1045-1051.
25. Soler, D., T. L. Humphreys, S. M. Spinola, and J. J. Campbell. 2003. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 101: 1677-1682.
26. Kudo, C., T. Yamashita, A. Araki, M. Terashita, T. Watanabe, M. Atsumi, M. Tamura, and F. Sendo. 1993. Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats. J. Immunol. 150: 3728-3738.
27. Larsen, C. G., M. K. Thomsen, B. Gesser, P. D. Thomsen, B. W. Deleuran, J. Nowak, V. Skodt, H. K. Thomsen, M. Deleuran, K. Thestrup-Pedersen, et al. 1995. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J. Immunol. 155: 2151-2157.
28. Morita, K., M. Miura, D. R. Paolone, T. M. Engeman, A. Kapoor, D. G. Remick, and R. L. Fairchild. 2001. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J. Immunol. 167: 2979-2984.
29. Tumpey, T. M., R. Fenton, S. Molesworth-Kenyon, J. E. Oakes, and R. N. Lausch. 2002. Role for macrophage inflammatory protein 2 (MIP-2), MIP- 1α, and interleukin-1α in the delayed hypersensitivity response to viral antigen. J. Virol. 76: 8050-8057.
30. Van Loveren, H., and P. W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133: 2397-2401.
31. Tsuji, R. F., G. P. Geba, Y. Wang, K. Kawamoto, L. A. Matis, and P. W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ: a possible initiating role of B cells. J. Exp. Med. 186: 1015-1026.
32. Tsuji, R. F., I. Kawikova, R. Ramabhadran, M. Akahira-Azuma, D. Taub, T. E. Hugli, C. Gerard, and P. W. Askenase. 2000. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165: 1588-1598.
33. Pior, J., T. Vogl, C. Sorg, and E. Macher. 1999. Free hapten molecules are dispersed by way of the blood stream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113: 888-893.
34. El-Sawy, T., M. Miura, and R. Fairchild. 2004. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate mediated inflammation and graft necrosis. Am. J. Pathol. 165: 147-157.
35. Miura, M., T. El-Sawy, and R. L. Fairchild. 2003. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-g. Am. J. Pathol. 162: 509-519.
36. Miura, M., X. Fu, Q.-W. Zhang, D. G. Remick, and R. L. Fairchild. 2001. Neutralization of Groα and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159: 2137-2145.
37. Rabb, H., Y. M. O'Meara, P. Maderna, P. Coleman, and H. R. Brady. 1997. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51: 1463-1468.
38. Bettelli, E., T. Korn, and V. K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19: 652-657.
39. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
40. Tzartos, J. S., M. A. Friese, M. J. Raner, J. Palae, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155.
41. Kawaguchi, M., F. Kokubu, H. Kuga, S. Matsaukura, H. Hoshino, K. Ieki, T. Imai, M. Adachi, and S. K. Huang. 2001. Modulation of bronchial epithelial cells by IL-17. J. Allergy Clin. Immunol. 108: 804-809.
42. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
43. Park, H., Z. Li, X. O. Yang, S. E. Chang, R. Nurieva, Y.-H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
44. Cruz, A., S. A. Khader, E. Torrado, A. Fraga, J. E. Pearl, J. Pedrosa, A. M. Cooper, and A. G. Castro. 2006. IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177: 1416-1420.
45. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
46. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8: 369-377.
47. Li, Q., P. W. Park, C. L. Wilson, and W. C. Parks. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 11: 635-646.
48. Cassatella, M. A., S. Gasperini, F. Calzetti, S. Bertagnin, A. D. Luster, and P. P. McDonald. 1997. Regulated production of the interferon-γ- inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27: 111-115.
49. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell a chemoattractant (I-TAC), and IFN-γ inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162: 4928-4937.
50. Miura, M., K. Morita, H. Kobayashi, T. A. Hamilton, M. A. Burdick, R. M. Strieter, and R. L. Fairchild. 2001. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J. Immunol. 167: 3494-3504.
51. Molesworth-Kenyon, S. J., J. E. Oakes, and R. N. Lausch. 2005. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. J. Leukocyte Biol. 77: 552-559.
52. Sitia, G., M. Isogawa, M. Iannacone, I. L. Campbell, F. V. Chisari, and L. G. Guidotti. 2004. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 113: 1158-1167.